FDA National Drug Codes
Searching…
FDA National Drug Codes
Searching…
FDA National Drug Codes
Browse every product in the FDA NDC Directory below, or search by NDC, brand, generic, manufacturer or HCPCS code. Each product has its own page with package NDCs in 11-digit billing format.
177 products match “Recombi” (finished products)
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Altuviiioantihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl | — | Kit | Bioverativ Therapeutics Inc. | 71104-979 |
| Altuviiioantihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl | — | Kit | Bioverativ Therapeutics Inc. | 71104-981 |
| Altuviiioantihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl | — | Kit | Bioverativ Therapeutics Inc. | 71104-982 |
| Altuviiioantihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl | — | Kit | Bioverativ Therapeutics Inc. | 71104-983 |
| Altuviiioantihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl | — | Kit | Bioverativ Therapeutics Inc. | 71104-984 |
| Arexvyrespiratory syncytial virus vaccine recombinant, adjuvanted | — | Kit | GlaxoSmithKline Biologicals SA | 58160-848 |
|---|
| Arexvyrespiratory syncytial virus vaccine recombinant, adjuvanted | — | Kit | GlaxoSmithKline Biologicals SA | 58160-882 |
|---|
| Arexvyrespiratory syncytial virus vaccine recombinant, adjuvanted | — | Kit | GlaxoSmithKline Biologicals SA | 58160-894 |
|---|
| BeneFIXcoagulation factor ix (recombinant) | — | Kit | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 58394-633 |
|---|
| BeneFIXcoagulation factor ix (recombinant) | — | Kit | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 58394-634 |
|---|
| BeneFIXcoagulation factor ix (recombinant) | — | Kit | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 58394-635 |
|---|
| BeneFIXcoagulation factor ix (recombinant) | — | Kit | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 58394-636 |
|---|
| BeneFIXcoagulation factor ix (recombinant) | — | Kit | Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 58394-637 |
|---|
| Darzalex Fasprodaratumumab and hyaluronidase-fihj (human recombinant) | Daratumumab 1800 mg/15mL; Hyaluronidase (Human recombinant) 30000 U/15mL | InjectionSubcutaneous | Janssen Biotech, Inc. | 57894-503 |
|---|
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-801 |
|---|
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-802 |
|---|
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-803 |
|---|
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-804 |
|---|
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-805 |
|---|
| Eloctateantihemophilic factor (recombinant), fc fusion protein | — | KitIntravenous | Bioverativ Therapeutics Inc. | 71104-806 |
|---|